1. The Migraine Stigma Kaleidoscope View

   • Elena Gross
   • Elena Ruiz de la Torre
   • Paolo Martelletti

   COMMENTARY Open access 05 March 2023 Pages: 703 - 709

   

2. Podcast on the Art of the Patient Conversation: Healthcare Provider Perspectives to Improve Outcomes in Multiple Sclerosis

   • Cortnee Roman
   • Denise Bruen

   COMMENTARY Open access 09 March 2023 Pages: 711 - 719

   

3. Clinical and Scientific Challenges to Effectiveness Studies Under Coverage with Evidence Development in Alzheimer’s Disease

   • Peter J. Morin
   • Quanwu Zhang
   • Amir Abbas Tahami Monfared

   COMMENTARY Open access 18 March 2023 Pages: 721 - 726

4. Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022

   • Carla Abdelnour
   • Maria Camila Gonzalez
   • Dag Aarsland

   REVIEW Open access 05 April 2023 Pages: 727 - 749

   

5. Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis

   • Yao-Chen Zhang
   • Ke-Yi Fan
   • Sheng-Xiao Zhang

   ORIGINAL RESEARCH Open access 04 March 2023 Pages: 751 - 762

   

6. Causal Relationship Between Basal Metabolic Rate and Alzheimer’s Disease: A Bidirectional Two-sample Mendelian Randomization Study

   • Yuexiao Zou
   • Qingxian Wang
   • Xiaorui Cheng

   ORIGINAL RESEARCH Open access 10 March 2023 Pages: 763 - 776

   

7. A Randomized, Double-Blind, Placebo-Controlled, Parallel Study Investigating the Efficacy of a Whole Coffee Cherry Extract and Phosphatidylserine Formulation on Cognitive Performance of Healthy Adults with Self-Perceived Memory Problems

   • Katarina M. Doma
   • Erin D. Lewis
   • Malkanthi Evans

   ORIGINAL RESEARCH Open access 16 March 2023 Pages: 777 - 794

   

8. Estimated Societal Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling

   • Amir Abbas Tahami Monfared
   • Weicheng Ye
   • Quanwu Zhang

   ORIGINAL RESEARCH Open access 16 March 2023 Pages: 795 - 814

   

9. Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans

   • Yu-Luan Chen
   • Hironobu Tsukada
   • Gerald R. Galluppi

   ORIGINAL RESEARCH Open access 17 March 2023 Pages: 815 - 832

   

10. Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis

    • Jai Perumal
    • Roumen Balabanov
    • Robert J. Fox

    ORIGINAL RESEARCH Open access 26 March 2023 Pages: 833 - 848

    

11. Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis in the United States

    • Daniel Kantor
    • Timothy Pham
    • Komal Gupte-Singh

    ORIGINAL RESEARCH Open access 31 March 2023 Pages: 849 - 861

    

12. A Path to Improved Alzheimer’s Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer’s Disease from the CLARITY AD Trial

    • Amir Abbas Tahami Monfared
    • Weicheng Ye
    • Quanwu Zhang

    ORIGINAL RESEARCH Open access 02 April 2023 Pages: 863 - 881

    

13. Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

    • Lilyana Amezcua
    • Yang Mao-Draayer
    • the ENDORSE Study Investigators

    ORIGINAL RESEARCH Open access 15 April 2023 Pages: 883 - 897

    

14. Understanding Barriers Along the Patient Journey in Alzheimer’s Disease Using Social Media Data

    • Amir Abbas Tahami Monfared
    • Yaakov Stern
    • Quanwu Zhang

    ORIGINAL RESEARCH Open access 15 April 2023 Pages: 899 - 918

    

15. Optimizing The Timing of Stereotactic Minimally Invasive Drainage for Hypertensive Intracerebral Hemorrhage

    • Jingchen Li
    • Zhiyong Li
    • Xiuwen Wu

    ORIGINAL RESEARCH Open access 18 April 2023 Pages: 919 - 930

    

16. Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age

    • Dominika Śmiałek
    • Katarzyna Kotulska
    • Sergiusz Jóźwiak

    ORIGINAL RESEARCH Open access 21 April 2023 Pages: 931 - 946

    

17. Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects

    • Beibei Liang
    • Jin Wang
    • Yun Cai

    ORIGINAL RESEARCH Open access 24 April 2023 Pages: 947 - 959

    

18. The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy

    • Yijie Feng
    • Yiqin Cui
    • Shanshan Mao

    ORIGINAL RESEARCH Open access 27 April 2023 Pages: 961 - 976

    

19. Frameless Robot-Assisted Asleep Centromedian Thalamic Nucleus Deep Brain Stimulation Surgery in Patients with Drug-Resistant Epilepsy: Technical Description and Short-Term Clinical Results

    • Changquan Wang
    • Jing Hong
    • Jiwen Xu

    Brief report Open access 09 March 2023 Pages: 977 - 993

    

20. Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease

    • Gustavo Saposnik
    • Gonzalo Sánchez-Benavidez
    • Jorge Maurino

    STUDY PROTOCOL Open access 23 March 2023 Pages: 995 - 1006

    

21. Familial Mediterranean Fever and Transverse Myelitis: A Causal Relation?

    • Ali Motahharynia
    • Ghazaal Alavi Tabatabaei
    • Iman Adibi

    CASE REPORT Open access 08 March 2023 Pages: 1007 - 1013